Icon taps Oracle for cloud-based trial management system; Medidata has new EVP of strategy and corporate development;

> Icon ($ICON), the Ireland-based CRO, has tapped Oracle ($ORCL) to provide technology for a web-based clinical trial management system. Article

> Medidata Solutions ($MDS), a provider of clinical trials software, has named Bryan Spielman to be of executive vice president of strategy and corporate development. Item

> McDougall Scientific has licensed TrialMaster software from OmniComm Systems, a provider of electronic data capture (EDC) software. Release

> Prognosys Biosciences said it has released a new cloud-based analysis service for next-generation sequencing data, with an initial capability to analyze RNA sequencing data from Illumina's ($ILMN) HiSeq and GAIIX sequencing systems. Item

> PointCross Life Sciences said it has won a contract from the FDA to provide the agency's toxicology reviewers with "an integrated off-the-shelf software environment comprising of a hosting repository, visualization and analysis functions and search and discovery capabilities." Release

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.